aTyr Pharma | LIFE - Equity Capital And Reserves


aTyr Pharma reported $-24.12M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Ardelyx USD 166.95M 12.67M Dec/2025
aTyr Pharma USD -24.12M 104.35M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Galapagos EUR 3.24B 788.91M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
United Therapeutics USD 7.1B 506M Dec/2025
Xoma USD 87.94M 15.5M Sep/2025